Yeong Kyun Bae
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yeong Kyun Bae has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Young Joo Sim
Department of Physical Medicine and Rehabilitation, Kosin University Gospel Hospital, Busan, Korea
2 shared publications Ghi Chan Kim
Department of Physical Medicine and Rehabilitation, College of Medicine, Kosin University Gospel Hospital, Busan, Korea
1 shared publication- Ghi Chan Kim
Department of Physical Medicine and Rehabilitation, Kosin University Gospel Hospital, Busan, Korea
1 shared publication - Han Eum Choi
Department of Physical Medicine and Rehabilitation, Kosin University College of Medicine, Busan, Korea
1 shared publication Ho Joong Jeong
Department of Physical Medicine and Rehabilitation, College of Medicine, Kosin University Gospel Hospital, Busan, Korea
1 shared publication- Ho Joong Jeong
Department of Physical Medicine and Rehabilitation, Kosin University Gospel Hospital, Busan, Korea
1 shared publication
Latest Publications
- 1 June 2022
- Published by SAGE Publications in Lymphatic Research and Biology
- Vol. 20 (3) , 302-307
Lymphedema Index Ratio As Predictive Factor of Treatment in Patients with Breast Cancer-Related Lymphedema
Background: This retrospective observational study aimed to evaluate the lymphedema index ratio to predict the effect of complex decongestive therapy (CDT) in patients with breast cancer-related lymphedema (BCRL) and to establish a lymphedema index ratio cutoff value for the extent of CDT effect. Materials and Methods: All 108 enrolled patients with BCRL underwent volume measurements and bioelectrical impedance analysis before and after CDT. The difference in percent excess volume (PEV) before and after CDT was defined as the therapeutic effect, and each patient was assigned to Groups A, B, or C based on therapeutic effects of 0%–5%, 5%–10%, and 10%–20%, respectively. Results: The mean lymphedema index ratios of Groups A, B, and C were 1.27, 1.38, and 1.46, respectively, with significant differences between the groups (p < 0.01). The cutoff lymphedema index ratio values for diagnosis between Groups A and B and between Groups B and C were 1.277 (sensitivity: 71.7%, specificity: 61.8%) and 1.357 (sensitivity: 76.9%, specificity: 62.1%), respectively. The Spearman coefficients for the linear relationship between lymphedema index ratio and initial PEV and between lymphedema index ratio and therapeutic effect were found to be significant at 0.615 and 0.360, respectively (p < 0.01). Conclusion: The results of this study found that the lymphedema index ratio may predict the volume reduction in patients with BCRL. A less reduction (therapeutic effect 1.357.
- 1 June 2022
- Published by SAGE Publications in Lymphatic Research and Biology
- Vol. 20 (3) , 302-307
Lymphedema Index Ratio As Predictive Factor of Treatment in Patients with Breast Cancer-Related Lymphedema
Background: This retrospective observational study aimed to evaluate the lymphedema index ratio to predict the effect of complex decongestive therapy (CDT) in patients with breast cancer-related lymphedema (BCRL) and to establish a lymphedema index ratio cutoff value for the extent of CDT effect. Materials and Methods: All 108 enrolled patients with BCRL underwent volume measurements and bioelectrical impedance analysis before and after CDT. The difference in percent excess volume (PEV) before and after CDT was defined as the therapeutic effect, and each patient was assigned to Groups A, B, or C based on therapeutic effects of 0%–5%, 5%–10%, and 10%–20%, respectively. Results: The mean lymphedema index ratios of Groups A, B, and C were 1.27, 1.38, and 1.46, respectively, with significant differences between the groups (p < 0.01). The cutoff lymphedema index ratio values for diagnosis between Groups A and B and between Groups B and C were 1.277 (sensitivity: 71.7%, specificity: 61.8%) and 1.357 (sensitivity: 76.9%, specificity: 62.1%), respectively. The Spearman coefficients for the linear relationship between lymphedema index ratio and initial PEV and between lymphedema index ratio and therapeutic effect were found to be significant at 0.615 and 0.360, respectively (p < 0.01). Conclusion: The results of this study found that the lymphedema index ratio may predict the volume reduction in patients with BCRL. A less reduction (therapeutic effect 1.357.
- Open Access
- 31 December 2021
- Published by Korean Association of EMG Electrodiagnostic Medicine in Journal of Electrodiagnosis and Neuromuscular Diseases
- Vol. 23 (3) , 71-75
Progressive Muscular Atrophy with Hypokalemic Periodic Paralysis: A Case Report
- 31 December 2021
- Published by Korean Association of EMG Electrodiagnostic Medicine in Journal of Electrodiagnosis and Neuromuscular Diseases
- Vol. 23 (3) , 71-75
Open AccessProgressive Muscular Atrophy with Hypokalemic Periodic Paralysis: A Case Report